Published on: Jan 08, 2016 at Journal of Clinical Pathways

Neoadjuvant chemo underused in patients with advanced gastric

By : Journal of Clinical Pathways

Neoadjuvant chemotherapy (NAC) remains underused in patients with advanced gastric cancer, despite evidence that it does not worsen perioperative outcomes, U.S. researchers report.

Read More
SHARE